Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information
Issue
Vol. 17. Issue 6.
Pages 897-1224 (November - December 2018)
Editorial
Financial and Other Competing Interests: Be Aware
Horacio Rivera, Arturo Panduro
Ann Hepatol. 2018;17:897-8
Open access
Opinion
The evolving role of liver biopsy in non-alcoholic fatty liver disease
Juan Pablo Arab, Francisco Barrera, Marco Arrese
Ann Hepatol. 2018;17:899-902
Open access
Viewpoint
Computed Tomography and Magnetic Resonance Imaging Features of Primary and Secondary Hepatic Glycogenosis
Zhi-yuan Chen, Yu-pin Liu, Guang-juan Zheng
Ann Hepatol. 2018;17:903-5
Open access
ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver Transplantation
Marcio F. Chedid, Rafael V. Picon, Aljamir D. Chedid
Ann Hepatol. 2018;17:906-7
Open access
Concise review
Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda-Granados, Alexis José-Ábrego, Nora A. Fierro, Sonia Román
Ann Hepatol. 2018;17:908-19
Open access
An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis
Andree H. Koop, Omar Y. Mousa, Ly Elaine Pham, Juan E. Corral-Hurtado, Surakit Pungpapong, Andrew P. Keaveny
Ann Hepatol. 2018;17:920-32
Open access
Original article
Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
Tsung-Hsing Hung, Chih-Wei Tseng, Hsing-Feng Lee, Chih-Chun Tsai, Chen-Chi Tsai
Ann Hepatol. 2018;17:933-9
Open access
The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes
Xiao-Mei Song, Qing-Ling Li, Feng Guo, Hong Peng, Jin-Jun Guo
Ann Hepatol. 2018;17:940-7
Open access
Infection and Predictors of Outcome of Cirrhotic Patients after Emergency Care Hospital Admission
Wajima Safi, Mayada Elnegouly, Raphael Schellnegger, Katrin Umgelter, Fabian Geisler, Wolfgang Reindl, Bernd Saugel, Alexander Hapfelmeier, Andreas Umgelter
Ann Hepatol. 2018;17:948-58
Open access
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
Mario G. Pessoa, José V. Ramalho-Madruga, Katia Alves, Estevão P. Nunes, Hugo Cheinquer, Carlos E. Brandão-Mello, Maria C. Mendes-Correa, Maria L. Ferraz, ... Ana Martinelli
Ann Hepatol. 2018;17:959-68
Open access
Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma
Samuel O. Antwi, Yacob Y. Habboush, Lori A. Chase, David D. Lee, Tushar Patel
Ann Hepatol. 2018;17:969-79
Open access
Hepatoprotective Role of Thymol in Drug-Induced Gastric Ulcer Model
Fatime Geyikoglu, Elif Gülcan Yilmaz, Huseyin Serkan Erol, Kubra Koc, Salim Cerig, Nihal Simsek Ozek, Ferhunde Aysin
Ann Hepatol. 2018;17:980-91
Open access
The -250G/A and -514C/T Polymorphisms in Hepatic Lipase Gene Promoter Confers an Increased Risk of Hepatocellular Carcinoma in a Chinese Population
Chuan-Zhen Niu, Fu-Hua Zhang, Yan Li, Jing-Jing Liu, Cui-Xia Bao
Ann Hepatol. 2018;17:992-1000
Open access
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Sidra Noor, Mohammad Ismail, Iqbal Haider, Faiza Khadim
Ann Hepatol. 2018;17:1001-11
Open access
MicroRNA Profile in Peripheral Blood Mononuclear Cells from Hepatitis B Virus Infected Patients
Kangkang Yu, Qian Li, Ning Li
Ann Hepatol. 2018;17:1012-20
Open access
Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis
Azizollah Yousefi, Mehri Najafi, Farzaneh Motamed, Elham Mahmoudi, Alireza Zare Bidoki, Maryam Sadr, Farzaneh Rahmani, Fatemeh Farhmand, ... Nima Rezaei
Ann Hepatol. 2018;17:1021-5
Open access
Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy
Plácido Espíritu-Ramírez, Nancy Y. Ortega-Balderas, Laura Sevilla-Tapia, Ana G. Montiel-Martínez, Ana R. Pastor-Flores, Laura A. Palomares, Miguel A. Torres-Vega
Ann Hepatol. 2018;17:1026-34
Open access
Association of Parity in Patients with Chronic Liver Disease
Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Carey Escheik, Mehmet Sayiner, Zobair M. Younossi
Ann Hepatol. 2018;17:1035-41
Open access
Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure
Sandeep Goyal, Shekhar Jadaun, Saurabh Kedia, Subrat Kumar Acharya, Sharat Varma, Baibaswata Nayak, Bhaskar Thakur, Shalimar
Ann Hepatol. 2018;17:1042-51
Open access
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas
Ahmet Gurakar, Michelle Ma, Jacqueline Garonzik-Wang, Amy Kim, Robert A. Anders, Kiyoko Oshima, Christos Georgiades, Merve Gurakar, ... Behnam Saberi
Ann Hepatol. 2018;17:1052-66
Open access
Case report
Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine?
Marion Lepelley, Marion Allouchery, Jérôme Long, Dorothée Boucherle, Yves Ranchoup, François Le Marc’Hadour, Céline Villier, Nathalie Sturm
Ann Hepatol. 2018;17:1067-71
Open access
Improvement in Waldenström’s Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals
Mattia Crespi, Maria Giulia Demarzo, Matteo Brunacci, Gaia Pellegatta, Fabio Ferrando, Alberto Ballestrero, Federica Grillo, Vincenzo Savarino, Edoardo G. Giannini
Ann Hepatol. 2018;17:1072-7
Open access
Correspondence
Thrombosis of the Portal Venous System in Cirrhotic Patients
Antonio Ponzetto, Natale Figura, Vania Cruz-Ramón, Paulina Chinchilla-López, Oscar Ramírez-Pérez, Nancy E. Aguilar-Olivos, Luis F. Alva-López, Ericka Fajardo-Ordoñez, ... Nahum Méndez-Sánchez
Ann Hepatol. 2018;17:1078-80
Open access
News
Special notice
An Ackowledgement
Ann Hepatol. 2018;17:1083-4
Open access
Index section
Abstract section
Index to volume
Subject Index
Ann Hepatol. 2018;17:1213-6
Open access
Author Index
Ann Hepatol. 2018;17:1217-24
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos